Sub-Saharan Africa would benefit most from new plan to control TB

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.583, 2009-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implementing adolescent HPV vax in sub-Saharan Africa

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 503, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Nevirapine prophylaxis cost effective in sub-Saharan Africa

By  

Inpharma, Vol. 1, Iss. 1261, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

The challenge of curbing the CVD burden in sub-Saharan Africa

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 550, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A missing piece in the puzzle: HIV in mature adults in sub-Saharan Africa

By Mutevedzi Portia C   Newell Marie-Louise  

Future Virology, Vol. 6, Iss. 6, 2011-06 ,pp. : 755-767

Future Medicine

Access to resources Recommend Favorite

Potential Natural Antimycobacterial Metabolites from Some Sub-Saharan Medicinal Plants

By N. Yong Joseph   Ntie-Kang Fidele  

Anti-Infective Agents, Vol. 12, Iss. 2, 2014-07 ,pp. : 178-190

Bentham Science Publishers

Access to resources Recommend Favorite